Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2020-08-13
2022-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reproducibility of the Measurement of the Right Portal Vein Diameter
NCT04617964
Fetal Aortic Pulsewave Velocity: A Novel Doppler Ultrasound Method of Measuring the Biophysical Properties of the Fetal Aorta
NCT00359034
Placental Insufficiency Microcirculation Quantification by Ultrafast Doppler (MICRODOPPLER PLACENTA)
NCT03860103
Uterine Artery Pulsatility Index and Materno Fetal Outcomes
NCT02853058
Validation of Ultrasound in Predicting a Low Lying Placenta Throughout Pregnancy
NCT02689739
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
women in the 1st trimester of pregnancy.
ultrasound
portal vein pulsatility fraction (percent) measured with ultrasound
women in the 2nd trimester of pregnancy.
ultrasound
portal vein pulsatility fraction (percent) measured with ultrasound
women in the 3rd trimester of pregnancy.
ultrasound
portal vein pulsatility fraction (percent) measured with ultrasound
non-pregnant women
ultrasound
portal vein pulsatility fraction (percent) measured with ultrasound
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrasound
portal vein pulsatility fraction (percent) measured with ultrasound
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists (ASA) Class I and II
* Singleton pregnancy during 1st, 2nd or 3rd trimester or healthy non-pregnant females of childbearing age as controls
Exclusion Criteria
* Multiple gestation
* Significant co-morbidities (e.g. cardiac abnormalities, cardiac dysfunction, arrhythmias, severe asthma, renal insufficiency)
* High risk pregnancies (e.g. pre-eclampsia, gestational hypertension, HELLP, gestational diabetes)
* Body-Mass-Index (BMI) \< 18kg/m2 or \>40kg/m2
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bigna Buddeberg, Dr. med.
Role: PRINCIPAL_INVESTIGATOR
Department of Anesthesiology, University Hospital Basel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Anesthesiology, University Hospital Basel
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-00774; qu19Buddeberg
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.